• Explore /
  • Poster
  • / Four-year survival in patients (pts) undergoing liver surgery after neoadjuvant triplet hepatic artery infusion (HAI) and intravenous cetuximab (IV-CET) for previously treated and unresectable liver metastases from kras <I>wt</I>  colorectal cancer (LM-CRC) (European trial OPTILIV, NCT00852228).

Four-year survival in patients (pts) undergoing liver surgery after neoadjuvant triplet hepatic artery infusion (HAI) and intravenous cetuximab (IV-CET) for previously treated and unresectable liver metastases from kras wt  colorectal cancer (LM-CRC) (European trial OPTILIV, NCT00852228).

Abstract Poster

Authors

null

Francis Levi

Medical Oncology Department, INSERM U776, Paul Brousse Hospital, Villejuif, France

Francis Levi , Michel Ducreux , Denis Michel Smith , Mohamed Hebbar , Céline Lepère , C. N. J. Focan , Rosine Guimbaud , Pasquale F. Innominato , Carlos Carvalho , Salvatore Tumolo , Stephanie Truant , Denis Castaing , Abdoulaye Karaboué , Valerie Boige , Mohamed Bouchahda , Philippe Rougier , Rene Adam

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Clinical Trial Registration Number

NCT00852228

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 3589)

DOI

10.1200/jco.2014.32.15_suppl.3589

Abstract #

3589

Poster Bd #

52

Abstract Disclosures

Similar Posters

First Author: Francis Levi

First Author: Francis Levi

First Author: Christopher Williams

First Author: Sherise C. Rogers